Cytodyn Inc (CYDY)

[stockorus]

This was a forced CC. Not to report material progress but to offset the sudden unexpected impact from FDA letter. So it is not surprising that the team is mentally tired having to do it, especially Nader. He wanted attention off FDA and on the practical next steps that they are trying to focus on. To talk on FDA negatively is counter-productive, so refused to go that direction. As for his "forward looking statements", guess that phrase gives them leeway to project /suggest as they please, then become silent later on. Going forward we have to focus on what actually has happened, and take anything else as only suggesting possible effort from Cytodyn in those directions and in no way a likely successful outcome.

For now, Brazil trials are on. In India there is communication going on for possible trial. All this fantasy about EUA or even CSP, revenue etc., shareholders should not be talking about too much. Yes, we desperately wanted such an outcome following CD12, but by now it is getting clear this is going to be a long drawn process (till year end), even though many a person around the world could possibly have been saved if there was interim EUA. The not-pretty way this system works.